Back to News
Market Impact: 0.05
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Source: zacks.com
Healthcare & Biotech
The iShares Biotechnology ETF (IBB) is described as a smart beta ETF designed to provide broad exposure to the Health Care ETFs category. It launched on February 5, 2001.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- RA Capital Management sells $9.13M in Lenz Therapeutics shares
- Karyopharm stock rating cut to neutral by Rodman on bankruptcy
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- Bright Minds shares fall as BTIG cuts price target on clinical hold
- Vertex Pharma meets Q3 estimates, raises revenue guidance